Latest News about NPCE
Recent news which mentions NPCE
   12 Health Care Stocks Moving In Monday's After-Market Session
   
  
  
  January 02, 2023
  From Benzinga
 From Benzinga
 
   12 Health Care Stocks Moving In Thursday's After-Market Session
   
  
  
  November 24, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  November 14, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  October 25, 2022
  From Benzinga
 
   NeuroPace, Inc. (NPCE) Q2 2022 Earnings Call Transcript
   
  August 12, 2022
  Tickers 
   NPCE
  
  
  From Motley Fool
 
   Earnings Scheduled For August 11, 2022
   
  
  
  August 11, 2022
  From Benzinga
 
   89 Biggest Movers From Friday
   
  
  
  June 21, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  June 02, 2022
  From Benzinga
 Tickers 
   NPCE
  
  
  From Motley Fool
 From Benzinga
 
   NeuroPace, Inc. (NPCE) Q4 2021 Earnings Call Transcript
   
  March 10, 2022
  Tickers 
   NPCE
  
  
  From Motley Fool
 
   Earnings Scheduled For March 10, 2022
   
  
  
  March 10, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  February 07, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  February 04, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  February 02, 2022
  From Benzinga
 
   The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
   
  
  
  January 12, 2022
  From Benzinga
 
   58 Biggest Movers From Yesterday
   
  
  
  December 14, 2021
  From Benzinga
 
   50 Biggest Movers From Yesterday
   
  
  
  November 30, 2021
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  November 11, 2021
  From Benzinga
 
   NeuroPace, Inc. (NPCE) Q3 2021 Earnings Call Transcript
   
  November 11, 2021
  Tickers 
   NPCE
  
  
  From Motley Fool
 
   The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
   
  
  
  November 11, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
